Biblio
Current assessment and management of measurable residual disease in patients with acute lymphoblastic leukemia in the setting of CAR-T-cell therapy. Chin Med J (Engl). 2023.
. Current status and future perspective of natural killer cell therapy for cancer. Med Rev (2021). 2023;3(4):305-320.
.